In conclusion, our study suggests that BSCAs can induce apoptosis in hepatocellular carcinoma cells and modulate the JAK2/STAT3 signaling pathway in hepatocellular carcinoma cells. The gene discussed is STAT3; the disease is hepatocellular carcinoma.